Lyons-Williams Lori

CIK 00016935644 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001693564

Recent Transactions

41 trades

Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2026-06-26+19,000→ 19,000 total
Disposition from Tender
RAPT Therapeutics, Inc.$RAPT
Common Stock
2026-03-03−4,956→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−2,813→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−1,063→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−1,618→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−4,561→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−32,229→ 0 total
Award
RAPT Therapeutics, Inc.$RAPT
Common Stock
2026-01-30+4,956→ 4,956 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2025-06-26+14,750→ 14,750 total
Award
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2025-05-29+257,832→ 257,832 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2024-05-24+29,500→ 29,500 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2024-05-22+36,490→ 36,490 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2023-05-24+12,940→ 12,940 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2022-05-25+8,500→ 8,500 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2021-11-09+22,500→ 22,500 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−20,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−25,000→ 0 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2020-05-14+20,000→ 20,000 total
Disposition to Issuer
Dermira, Inc.
Common Stock
2020-02-20$18.75/sh−25,401→ 0 total
Disposition to Issuer
Dermira, Inc.
Employee Stock Options (Right to buy)
2020-02-20−100,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Employee Stock Options (Right to buy)
2020-02-20−65,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−15,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Employee Stock Options (Right to buy)
2020-02-20−63,750→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−6,378→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−30,000→ 0 total
Exercise/Conversion
Dermira, Inc.
Common Stock
2019-08-15+3,189→ 26,983 total
Tax Payment
Dermira, Inc.
Common Stock
2019-08-15$7.91/sh−1,582→ 25,401 total
Exercise/Conversion
Dermira, Inc.
Restricted Stock Unit
2019-08-15−3,189→ 6,378 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2019-06-23+25,000→ 25,000 total
Exercise/Conversion
Dermira, Inc.
Common Stock
2019-05-17+30,000→ 34,168 total
Exercise/Conversion
Dermira, Inc.
Restricted Stock Unit
2019-05-17−30,000→ 30,000 total
Tax Payment
Dermira, Inc.
Common Stock
2019-05-17$10.50/sh−10,374→ 23,794 total
Award
Dermira, Inc.
Employee Stock Options (Right to buy)
2019-02-12+65,000→ 65,000 total
Award
Dermira, Inc.
Restricted Stock Unit
2019-02-12+15,000→ 15,000 total
Tax Payment
Dermira, Inc.
Common Stock
2018-08-15$9.58/sh−368→ 2,616 total
Award
Dermira, Inc.
Restricted Stock Unit
2018-08-15+60,000→ 60,000 total
Exercise/Conversion
Dermira, Inc.
Common Stock
2018-08-15+1,063→ 2,984 total
Exercise/Conversion
Dermira, Inc.
Restricted Stock Unit
2018-08-15−1,063→ 9,567 total
Award
Dermira, Inc.
Employee Stock Options (Right to buy)
2018-02-15$28.25/sh+63,750→ 63,750 total
Award
Dermira, Inc.
Restricted Stock Unit
2018-02-15+10,630→ 10,630 total
Award
Dermira, Inc.
Employee Stock Options (Right to buy)
2017-01-09+100,000→ 100,000 total

Companies

Recent Filings

Address

3565 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov